Navigation Links
PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
Date:10/16/2007

DES MOINES, Iowa, Oct. 16 /PRNewswire/ -- Protocol Driven Healthcare, Inc. (PDHI) today launched ConXus(R) Rewards and announced a partnership with Hallmark Insights to provide fully integrated incentive management and fulfillment services to users of the ConXus health improvement platform.

ConXus Rewards delivers incentive management and fulfillment services for reward points earned by participants completing activities within the ConXus health improvement platform. Activities include completion of a health risk assessment using ConXus Profile or completion of portions of a health action plan using ConXus Steps. Two options are available:

1. With integrated fulfillment services, delivered in partnership with

Hallmark Insights

2. With tracking and management of reward points earned only, for

fulfillment by the client or employer end client outside the ConXus

platform

Clients may offer fulfillment services by employer, supporting flexible service delivery.

"The value of incentives in health and wellness programs is well proven," says Jennifer Jolley, President of PDHI. "The challenge has been delivering a cost-effective, scalable solution. Working with Hallmark Insights enables us to offer the ConXus solution to automate reward fulfillment, together with essential program administration processes such as billing, payment, and reporting."

Participants earn points for completing activities within the ConXus modules, based on client business rules. The maximum reward points available may be set by each employer for each wellness cycle, typically a year. Individual point-earning activities, total to date, and budget available are displayed to each participant and can be reviewed in aggregate by program administrators using online reporting tools.

For employers that choose Hallmark Insights fulfillment services, reward points earned are transferred to Hallmark Insights in real time. Participants i
'/>"/>

SOURCE Protocol Driven Healthcare, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
2. Sygnis Pharma AG announces date for presentation of clinical results
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... , May 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... been named the 2013 Life Science Firm of the Year ... (TCM).  Vanda was honored at the TCM,s 25 th ... , Maryland.  The Tech Awards Celebration recognizes the leaders and ... Maryland and the surrounding regions. ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
(Date:5/23/2013)...  Hadasit Bio-Holdings Ltd. (TASE: HDST, OTC: HADSY), ... on intellectual property developed and owned by Hadassah ... medical research center, today announced that its portfolio ... from the Israeli Ministry of Industry and Commerce, ... product development and advance clinical trials. Cell Cure,s ...
Breaking Medicine Technology:Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4Hadasit Bio-Holdings Ltd. Portfolio Company - Cell Cure Neurosciences Ltd. Received Additional Government Support 2
... DETROIT , March 11 Caraco ... launched oxaliplatin injections. These 50mg and 100mg oxaliplatin injections, ... approval from the US Food and Drug Administration (FDA) ... is an anticancer used in the treatment of colon ...
... today the commercial launch of its new VivoTag ® 680 XL fluorescent dye for labeling biomolecules in a broad range of ... ... ... ...
Cached Medicine Technology:Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 2Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Eloxatin(R) 3VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 2VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 3VisEn Launches New VivoTag(R) 680 XL Fluorescence Molecular Imaging Label 4
(Date:5/24/2013)... Wednesday, 15th May 2013 | 10am BST | 5pm ... playback: http://bit.ly/10Rt0ZH , Ongoing regulatory changes are likely ... globe and particularly in Europe, a number of these new ... For dealmakers, understanding how the likes of Basel iii, Solvency ... corner of the market will give you a competitive edge ...
(Date:5/24/2013)... 2013 HCG EZ Drops has been ... to announce it’s new weight loss initiative. “We are so confident ... our customers their money back if they don’t lose 21 pounds ... EZ Drops. “The HCG Diet consists of 21 days of ... in 21 days.” , The controversial, cutting-edge diet has been hailed ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 The leading retail ... discount offer on short prom dresses . Now that ... that is standard with the brand name since its origin. ... in prom dresses. And now this huge discount offer will ... “I feel highly privileged to announce that Short ...
(Date:5/23/2013)... Los Angeles, CA (PRWEB) May 23, 2013 ... healthcare delivery has been gradually transforming, which has affected ... by medical school debt and seeking regular hours, more ... instead joining hospitals or other medical groups,” says IBISWorld ... operating costs and reimbursement pressure, a number of older ...
(Date:5/23/2013)... PHILADELPHIA, May 24, 2013 -- High blood glucose is ... of intensive insulin therapy (IIT) to control hyperglycemia is ... does not show a consistent benefit and even shows ... the American College of Physicians, (ACP) Clinical Guidelines Committee ... the American Journal of Medical Quality . , ...
Breaking Medicine News(10 mins):Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 3Health News:short prom dresses Offers Abnormally Low Discount on Its New Collections 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Medical Group Practice Management in the US Industry Market Research Report Now Available from IBISWorld 3Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2
... readmitted within a year, study finds , , WEDNESDAY, April ... discharged from the hospital is readmitted within 30 days, ... a year, a new study finds. , The groundbreaking ... that researchers believe could be prevented through better care ...
... Calif., April 1, 2009 UC Irvine pharmacological researchers ... regulation can limit cocaine cravings. Their findings could herald ... Shinjae Chung and Olivier Civelli, the study identified how ... "pleasure center" to create an addictive response to cocaine ...
... NVAX) announced today that it has ... common stock at $0.88 per share to a wholly owned subsidiary ... Novavax and Cadila. Novavax intends to use the $11 million in ... 4.75% senior convertible notes due in July 2009 and for a ...
... April 1 Medicare beneficiaries who need physical ... efficient to obtain treatment under legislation introduced yesterday ... Patient Access to Physical Therapists Act (HR 1829), ... (R-PA), and Tammy Baldwin (D-WI), eliminates the need ...
... AILA believes this reform must include a rational model for giving American ... that can open the door to innovation and international markets. , ... ... fuel to speed it to recovery. And, once recovered, it ...
... April 1 On April 1st, Professional Healthcare Resources ... patients in their homes. The company was started in ... and has grown to an organization offering home health, ... of Columbia, and Virginia. The company has over 700 ...
Cached Medicine News:Health News:High Rate of Rehospitalizations Costing Billions 2Health News:High Rate of Rehospitalizations Costing Billions 3Health News:UCI researchers find new way to fight cocaine addiction 2Health News:Novavax Announces Closing of $11 Million Common Stock Sale to Subsidiary of Cadila Pharmaceuticals 2Health News:Legislation Aims to Increase Access to Physical Therapist Services By Eliminating Physician Referral Requirement 2Health News:Legislation Aims to Increase Access to Physical Therapist Services By Eliminating Physician Referral Requirement 3Health News:AILA Believes There Has To Be a Better Way When It Comes to the H-1B Lottery 2Health News:AILA Believes There Has To Be a Better Way When It Comes to the H-1B Lottery 3Health News:Professional Healthcare Resources Celebrates 15 Year Anniversary 2
... is the first truely web-based solution on the ... POC (managed from the lab) and Critical Care ... of AegisPOC ensures that all groups have the ... in the manner best suited to them. Through ...
...
... The Vari-Lase Endovenous Laser System is ... for varicose veins in the leg. Endovenous ... surgical vein-stripping for the treatment of varicose ... laser fiber is inserted into the varicosed ...
Using proven 1064 nm technology for the treatment of deeper lesions, the Lumenis One Multi-Spot Nd:YAG module provides versatility allowing targeted treatment of leg veins, vascular lesions, facial w...
Medicine Products: